Company: GCTS
Filing Date: 2025-04-01
Form Type: S-3
Source: 0000950170-25-048684
Chunk: 2

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-04-01
Form: S-3
Chunk 2
---
us will be specified in a prospectus supplement to the base prospectus. The sales agreement prospectus immediately follows the base prospectus. Upon termination of the sales agreement with B. Riley Securities, Inc. and H.C. Wainwright & Co., LLC as sales agents, any portion of the $75,000,000 of securities included in the sales agreement prospectus that remains unsold pursuant to the sales agreement will be available for sale in other offerings pursuant to the base prospectus and a corresponding prospectus supplement, and if no shares are sold under the sales agreement, the full $75,000,000 of securities not sold may be sold in other offerings pursuant to the base prospectus and a corresponding prospectus supplement.

The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

$200,000,000 GCT Semiconductor Holding, Inc. Common Stock Preferred Stock Debt Securities Warrants Rights Units We, from time to time, may offer and sell, in one or more offerings, up to $200,000,000 of any combination of shares of our common stock (“Common Stock”), shares of our preferred stock, debt securities, warrants (“Warrants”), rights and units. We may offer and sell these securities in amounts, at prices and on terms determined at the time of the offering. This prospectus describes the general terms of these securities and the general manner in which these securities will be offered. Each time securities are offered under this prospectus, we will provide a prospectus supplement and attach it to this prospectus. The prospectus supplement will contain more specific information about the terms of the offering and the offered securities and may also supplement, update or amend information contained in this prospectus. We may offer and sell these securities to or through underwriters, dealers or agents, directly to purchasers or through a combination of these methods. If we use underwriters, dealers or agents to sell these securities, we will name them and describe their compensation arrangements in the prospectus supplement relating to such offering. Our Common Stock and Warrants are traded on the New York Stock Exchange under the symbols “GCTS” and “GCTS-WT,” respectively. On March 28, 2025, the closing price of our Common Stock was $1